Journey Medical Corp (DERM)
3.43
-0.06
(-1.72%)
USD |
NASDAQ |
Apr 24, 16:00
3.43
0.00 (0.00%)
After-Hours: 20:00
Journey Medical Price to Book Value: 3.360 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 3.418 |
| April 22, 2024 | 3.467 |
| April 19, 2024 | 3.409 |
| April 18, 2024 | 3.506 |
| April 17, 2024 | 3.781 |
| April 16, 2024 | 3.722 |
| April 15, 2024 | 3.938 |
| April 12, 2024 | 4.329 |
| April 11, 2024 | 4.222 |
| April 10, 2024 | 4.290 |
| April 09, 2024 | 3.918 |
| April 08, 2024 | 4.026 |
| April 05, 2024 | 3.604 |
| April 04, 2024 | 4.270 |
| April 03, 2024 | 3.350 |
| April 02, 2024 | 3.330 |
| April 01, 2024 | 3.242 |
| March 28, 2024 | 3.604 |
| March 27, 2024 | 3.694 |
| March 26, 2024 | 3.504 |
| March 25, 2024 | 2.773 |
| March 22, 2024 | 3.134 |
| March 21, 2024 | 3.627 |
| March 20, 2024 | 3.646 |
| March 19, 2024 | 3.599 |
| Date | Value |
|---|---|
| March 18, 2024 | 3.551 |
| March 15, 2024 | 3.229 |
| March 14, 2024 | 3.295 |
| March 13, 2024 | 3.238 |
| March 12, 2024 | 3.304 |
| March 11, 2024 | 3.200 |
| March 08, 2024 | 3.276 |
| March 07, 2024 | 3.295 |
| March 06, 2024 | 3.314 |
| March 05, 2024 | 3.542 |
| March 04, 2024 | 3.798 |
| March 01, 2024 | 3.922 |
| February 29, 2024 | 3.751 |
| February 28, 2024 | 3.466 |
| February 27, 2024 | 3.855 |
| February 26, 2024 | 3.580 |
| February 23, 2024 | 3.466 |
| February 22, 2024 | 3.561 |
| February 21, 2024 | 3.570 |
| February 20, 2024 | 3.542 |
| February 16, 2024 | 4.045 |
| February 15, 2024 | 4.178 |
| February 14, 2024 | 4.235 |
| February 13, 2024 | 4.273 |
| February 12, 2024 | 4.700 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7708
Minimum
Dec 21 2022
10771.54
Maximum
Sep 21 2023
890.79
Average
2.232
Median
Feb 16 2022
Price to Book Value Benchmarks
| Fortress Biotech Inc | 1.527 |
| Puma Biotechnology Inc | 4.361 |
| GT Biopharma Inc | 0.6741 |
| FibroGen Inc | -- |
| Outlook Therapeutics Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 0.8249 |
| Price to Free Cash Flow | 272.15 |
| Price | 3.43 |
| Earnings Yield | -10.20% |
| Market Cap | 68.37M |
| Operating PE Ratio | 61.04 |